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Abstract
White matter (WM) abnormalities have already been shown in presymptomatic (Pre-HD) and symptomatic HD subjects
using Magnetic Resonance Imaging (MRI). In the present study, we examined the microstructure of the long-range large
deep WM tracts by applying two different MRI approaches: Diffusion Tensor Imaging (DTI) -based tractography, and
T2*weighted (iron sensitive) imaging. We collected Pre-HD subjects (n = 25), HD patients (n = 25) and healthy control
subjects (n = 50). Results revealed increased axial (AD) and radial diffusivity (RD) and iron levels in Pre-HD subjects compared
to controls. Fractional anisotropy decreased between the Pre-HD and HD phase and AD/RD increased and although
impairment was pervasive in HD, degeneration occurred in a pattern in Pre-HD. Furthermore, iron levels dropped for HD
patients. As increased iron levels are associated with remyelination, the data suggests that Pre-HD subjects attempt to repair
damaged deep WM years before symptoms occur but this process fails with disease progression.
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Introduction
Huntington’s disease (HD) is a neurodegenerative autosomal
dominate disorder caused by increased CAG repeats, this leads to
increased accumulation of mutant huntingtin, and formation of
intranuclear inclusions and eventually to brain damage. Damage
has long been thought to start in the striatum (for review see: [1]),
however, most areas of the brain show abnormalities. Of the
abnormalities found in the HD brain, the changes to white matter
in particular have been become a major focus of research.
A model for the white matter changes in HD has been
formulated [2], which suggests that the pathogenesis of HD begins
with a deleterious effect of the mutant huntingtin on myelin.
Indeed mutant huntingtin is not found in higher levels in the
neurons that degenerate first, rather the mutated protein is
expressed throughout the nervous system and periphery [3]. This
implies that its primary impact may not be on neurons. The
myelin breakdown is, in turn, associated with increased density of
oligodendrocytes in the brain, which are involved in repairing
myelin damage. As the oligodendrocytes have the highest iron
content, when they increase in number, iron content increases [2].
Abnormalities in white matter cause downstream effects
through a complex physiological process that is still being
uncovered (see [4] for a summary). In short, oligodendrocytes
and myelin abnormalities can slow or stop fast axon transport,
which can result in synaptic loss and eventually axonal degener-
ation in a retrograde, (‘‘Dying back’’) fashion [5].
In the last decades in-vivo Magnetic Resonance Imaging (MRI)
investigations have revealed the extent of changes to white matter
in HD. MRI research has reported extensive white matter volume
loss in the whole brain [6], in the frontal lobe [7] and across the
total cerebrum [8], as well as changes to white matter microstruc-
ture; the motor cortico-striatal circuit [9–12], sensorimotor cortex,
[10], corpus callosum [11,13], and across extensive distributed
white matter fibers (corpus callosum, superior and inferior
longitudinal fasciculi and external capsule) [12]) years before
symptoms occur.
The increasing evidence that white matter is negatively
impacted in HD even before disease onset (Pre-HD) has led us
to investigate the changes in the large white matter tracts in Pre-
HD and HD and how these changes were related to the iron
content. We first investigated the corpus callosum and found that
early callosal white matter demyelination damage characterizes
HD in the pre-symptomatic stage [11]. At that clinical stage, the
myelin breakdown starts at the level of the early and heavily
myelinated callosal fibres [14]. Changes in iron content (reduction)
manifest in the early stages of HD, likely indicating a failure of the
remyelination processes at that time. Then we focused on the
cortical spinal tract, which is the brain’s main motor fiber [15]. We
found that a likely active repair mechanism (as indicated by
increased iron) helps keep the cortical spinal tract at a normal
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functional level in the presymptomatic stage. However, this repair
seems to fail with disease progression and cortical spinal white
matter tract damage becomes extensive in HD patients. The
damage to the cortical spinal white matter tract appears to occur
in a retrograde (‘‘Dying back’’) fashion, similar to what happens in
striatal and cortical projection neurons [5,16].
In the present study we were interested in making a step
forward, by investigating the whole deep white matter in HD,
definable as the large easily identifiable association white matter
tracts, i.e. the arcuate fasciculus (AF), the superior longitudinal
fasciculus (SLF), the cingulate (Cing), the inferior longitidinal
fasciculus (ILF), the inferior occipital fasciculus (IFO), the anterior
thalamic radiation (ATR) and the uncinate fasciculus (UF). We
studied the deep white matter tracts both as a combined whole
(called from now on ‘‘total deep white matter’’) in order to
investigate the disease effect on deep white matter in general and
as single tracts (AF, SLF, Cing, ILF, IFO, ATR, and UF; we will
refer to them as ‘‘individual deep white matte tracts’’) in order to
identify possible regional variations in the disease process.
With the white matter model in mind, we adopted two different
MRI approaches to investigate the deep white matter in HD:
Diffusion Tensor Imaging (DTI)-based tractography and
T2*weighted imaging.
DTI is the MRI technique most frequently used to study white
matter fiber changes. It is a non-invasive technique that uses local
water diffusion in the brain tissue. Although the biological
determinants of diffusion parameters (fractional anisotropy-FA,
axial diffusivity-AD and radial diffusivity-RD) are not yet fully
understood (for a discussion on diffusion imaging see [17], it is
agreed that this approach is sensitive to microstructural tissue
properties. Indeed, it has been used in numerous studies to
investigate everything from the effects of age on white matter in
healthy subjects [18] to disease effects in Alzheimer’s disease [19]
and schizophrenia [20].
T2* weighted volumes, which are sensitive to iron/ferritin
[21,22] are useful to investigate the iron content that is associated
with the remyelination process [2]. The few studies present in
literature show a non-univocal picture of the regional white matter
iron content changes in HD, with no iron level differences in the
callosal splenium, but decreased iron levels in the frontal lobe
white matter [2], the callosal isthmus [14] and the cortical spinal
white matter tract [15]. However, no studies to date in HD have
combined the sensitivity of DTI tractography to identify the deep
white matter in-vivo with T2* weighted volume images. By
combining these imaging methods in a large cohort of subjects (25
HD patients, 25 Pre-HD and 50 healthy subjects), we can assess
the effect HD has on the deep white matter tissue microstructure
(total and individual tracts).
The main aims of our study were the following: 1) to examine
total deep white matter microstructure in Pre-HD subjects and
HD patients; 2) to investigate whether variations in connectivity
parameters (FA, AD, RD) and in iron level within the deep white
matter provide evidence for the white matter demyelination and
remyelination model in HD; 3) to explore whether white matter
microstructural properties vary by individual deep white matter
tract in a particular manner.
Methods
Subjects
Subject demographics and clinical assessments are outlined in
Table 1. HD patients (n = 25) and Pre-HD subjects (n = 25),
underwent a genetic test (abnormal CAG repeats $36) and were
examined clinically by the same neurologist (FS) with expertise in
HD. All individuals were assessed using the Unified Huntington’s
Disease Rating Scale (UHDRS), which includes motor, cognitive,
behavioral, and functional subscales [23]. Each section consists of
a multistep subscale. The motor section measures eye movements,
limb coordination, tongue impersistence and movement disorders
(such as rigidity, bradykinesia, dystonia, chorea, and gait
disturbances). A higher score means more motor impairment.
The cognitive scale mainly evaluates executive function. A higher
score means better cognitive performance. The behavioral section
investigates the presence of depression, aggressiveness, obsessions/
compulsions, delusions/hallucinations and apathy. A higher score
means more impairment. The functional assessments include the
HD functional capacity scale (HDFCS), the independence scale
and a checklist of common daily tasks. All three scales mainly
investigate independence in daily life activities. The HDFCS is
reported as the total functional capacity (TFC) score (range 0–13)
and is the only functional subscale with established psychometric
properties (including inter-rater reliability and validity), which are
based on radiographic measures of disease progression. Thus, the
TFC score is used worldwide to determine patients’ HD stage. On
the independence scale, the investigator indicates whether the
patient can perform the task that evaluates independence level
(range 10–100). The checklist (functional assessment) is summed
by giving a score of 1 to all ‘‘yes’’ answers (range 0–25). Pre-HD
are defined as those subjects whom the suspected clinical diagnosis
is confirmed by DNA analysis, which revealed (CAG)(n) expansion
into the range characteristic of Huntington disease (.36 or
repeats), but who do not have manifested Huntington’s disease
symptoms yet defined by a total motor score of,5 in the UHDRS
and cognitive and behavioral assessment within the normality.
The Disease Burden index, a measure of disease severity, was used
according to the already described formula (age6[CAG-35.5]),
where CAG is the number of CAG repeats [24]. A higher score
reflects increased disease severity. The Mini Mental State
Examination (MMSE) [25], which measures global cognitive
functioning, was administered to Pre-HD subjects and HD
patients. A lower score reflects greater impairment.
Fifty individually healthy subjects were recruited from the
community. Patients in the advanced stages of disease (Stages III
and IV) and/or with traumatic brain injury or focal lesions were
excluded.
Ethics Statement
Presymptomatic test, genetic diagnosis and clinical exams were
performed at Neurological Research Institute IRCCS Neuromed.
All participants had the cognitive capacity to understand the
research protocol and gave their oral and written consent.
Cognitive capacity to consent was determined the MMSE. No
subjects had cognitive impairment (see score on Table 1). In no
case was there a surrogate consent procedure consented on the
behalf of participants. Consent was obtained according to the
Declaration of Helsinki and the Santa Lucia Foundation Research
Ethics Committee approved the study.
MRI Data Acquisition
All MRI data was acquired on a 3T Allegra MRI system
(Siemens, Germany) using a birdcage head coil. Scans were
collected in a single session, with the following pulse sequences: 1)
proton density and T2-weighted double turbo spin echo (SE)
acquired in transverse planes (time repetition [TR]: 4500 ms, time
echo [TE]: 12 ms, time to inversion [TI]: 112 ms, field of view
[FOV]: 2306172 mm, matrix: 3206240, slice thickness: 5 mm,
number of slices: 24); 2) fluid-attenuated inversion recovery in the
same planes as the SE sequence (TR/TE/TI: 8500/109/
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2000 ms; FOV: 2306168 mm, matrix: 2566256, slice thickness:
5 mm, number of slices: 24); 3) T1-weighted 3D images, with
partitions acquired in the sagittal plane, using a modified driven
equilibrium Fourier transform [26] sequence (TE/TR/TI: 2.4/
7.92/910 ms, flip angle: 15u, 1 mm3 isotropic voxels); and 4)
diffusion-weighted volumes were also acquired using SE echo-
planar imaging (TE/TR: 89/8500 ms, bandwidth: 2126 Hz/
voxel, matrix: 1286128, 80 axial slices, voxel size:
1.861.861.8 mm) with 30 isotropically distributed orientations
for the diffusion sensitizing gradients at a b value of 1000 s/mm2
and 6 b=0 images. Scanning was repeated 3 times to increase the
signal-to-noise ratio.
Six consecutive T2*-weighted gradient echo-planar whole-brain
volumes were acquired at different time of echo (TE) (TEs: 6, 12,
20, 30, 45 and 60 ms; TR=5000; bandwidth = 1116 Hz/vx;
matrix size 1286128680; flip angle 90u; voxel size of
1.561.562 mm3).
Images were visually inspected for gross anatomical abnormal-
ities by 2 experienced observers (a neuropsychologist expert in
neuroimaging and a neuroradiologist) blind to participant
identities.
Images were also visually inspected for movement artifacts,
which are a common source of concern while studying HD. Since
movement can compromise tracking, we excluded subjects who
had excessive movement in their scans.
DTI Processing
Diffusion-weighted images were processed with FMRIB’s
Software Library (FSL 4.1 www.fmrib.ox.ac.uk/fsl/). Images were
corrected for eddy current distortion. The non-diffusion-weighted
images were skull stripped using FSL’s Brain Extraction Tool
(BET) (http://www.fmrib.ox.ac.uk/fsl/bet2/index.html), and
used to mask all diffusion-weighted images. A diffusion tensor
model was fitted at each voxel using Diffusion Toolkit, generating
FA, AD, and RD maps. RD was defined as the average of the
second and third eigenvalues of the diffusion tensor, while AD
corresponded to the first eigenvalue.
T2*weighted images processing
T2*weighted volumes were post processed accordingly to
previously published methods [21,27]. Briefly the six T2*weighted
volumes were averaged in order to generate a mean T2*-weighted
volume. A full affine 3D alignment was calculated between each of
the six T2*-weighted volumes and the mean T2*-weighted
volume. For each subject we performed a voxel-by-voxel nonlinear
least-squares fitting of the data acquired at the six TEs to obtain a
mono-exponential signal decay curve. In order to facilitate analysis
of relaxation results, we considered the inverse of relaxation times,
i.e. relaxation rates R2*= 1/T2*61000.
Iron images (R2*) were registered into subject DTI space using
FSL Flirt 12 degree of freedom transformation with the DTI B0
image used as the reference image. Registrations were visually
inspected for accuracy.
Tractography
Tractography methods are outlined in more detail in [28],
however, the tractography and ROI drawing was modified to use
TrackVis, an interactive environment for fiber tracking recon-
struction, display and analysis developed at the Harvard Medical
School Martinos Center for Biomedical Imaging at Massachusetts
General Hospital (www.trackvis.org). The FACT approach was
used to reconstruct fiber paths. A track angle threshold of 35u was
used as well as an image mask based on the B0 image to restrict
tracking to biologically plausible results.
Table 1. Sociodemographic and clinical characteristics of patients and control subjects.
Pre-HD (n=25) HD (n=25) Controls (n =25)
Fisher’s Exact
Test; F or T Test df p
Characteristics
Gender male/female 16/9 14/11 30/20 0.367 2 0.833
Age (years 6 SD) 37.4467.01 47.40614.53 42.88612.48 4.349 2 0.012a{{
CAG repetition length 43.2862.17 46.6866.80 NA 22.380 48 0.021a{{
MMSE 27.8261.24 24.9763.23 NA 3.682 38 0.001b{{
UHDRS Motor 8.0069.28 37.22613.18 NA 28.695 44 0.001a{{
UHDRS Cognitive 257.80642.34 142.65650.35 NA 8.046 41 0.001b{{
UHDRS Behavioural 7.6767.84 18.3969.13 NA 24.160 42 0.001a{{
UHDRS Functional 2560 17.9165.68 NA 5.984 44 0.001b{{
TFC 1360 8.3962.37 NA 9.329 44 0.001b{{
Independence scale 99.861.04 78.04612.49 NA 8.312 44 0.001b{{
Disease burden 292.3687.52 458.66104.75 NA 26.091 48 0.001a{{
Legend. HD=Huntington’s disease; Pre-HD=gene-positive, without motor symptoms; SD= standard deviation; df = degrees of freedom; CAG, trinucleotide repeat
number; MMSE =Mini Mental State Examination; UHDRS =Unified Huntington’s Disease Rating Scale; TFC = Total Functional Capacity; NA=Not Available;
{{T-student, Bonferroni correction.
aPre-HD,HD (when referred to a cognitive scale comparison or CAG repetition, higher punctuations mean greater impairment).
bPre-HD.HD (when referred to a cognitive scale comparison, higher punctuations mean lesser impairment).
*MMSE: Missing data for 5 Pre-HD & 5 HD subjects.
*UHDRS Motor: Missing data for 2 Pre-HD & 2 HD subjects.
*UHDRS Cognitive: Missing data for 5 Pre-HD & 2 HD subjects.
*UHDRS Behavioral: Missing data for 4 Pre-HD & 2 HD subjects.
*UHDRS Functional: Missing data for 2 Pre-HD & 2 HD subjects.
*TFC: Missing data for 2 Pre-HD & 2 HD subjects.
doi:10.1371/journal.pone.0109676.t001
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Tractography of the total deep white matter was performed by
manually drawing regions of interest on each individuals FA color
map by a single expert (O.P.) who was blinded to subject age,
gender, and diagnosis. To determine intra-rater reliability, fiber
tracts were identified in 10 randomly chosen brain volumes.
Reliability was assessed using the intraclass correlation coefficient
(2-way mixed for intra-rater). The advantage of DTI-based
tractography is that the tracts can be precisely mapped within
subjects without the reliance on registration prodedures to align
imaging data across subjects [28].
Region of interest placement for the AF, SLF, Cing, ILF, IFO,
ATR, and UF was based on Wakana, et al [28]. The total deep
white matter was for the present study considered to be the
combined white matter of the individual tracts (AF, SLF, Cing,
ILF, IFO, ATR, and UF). FA, AD, RD, and iron were calculated
for each subject by averaging all voxels over the total deep white
matter and separately for each individual tract, counting each
voxel only once. Excellent intra-reliability was achieved for ROI
placement, as determined by computing the intra-class correlation
coefficients for tract volume and mean FA, AD, RD and Iron
(Table S1). It is important to note, that the specific anatomical
delineations for the deep white matter tracts are still emerging. For
example, the ILF in [28], may include the middle longitudinal
fasciculus (see [29] and the specific delineations of the SLF and AF
(temporal component of the SLF) has been a source on contention,
[30].
Statistical Analysis
Demographic differences were assessed using chi-square,
independent sample t-tests or Anova as appropriate. All statistical
analyses were performed using SPSS 14.0.
To test for total deep white matter differences among groups, a
Multivariate Analysis of Variance (Manova) was applied to all
three groups (healthy controls, HD patients and Pre-HD subjects).
Sex and age were included as covariates in the model. After that,
contrasts were run to individuate the significant difference between
groups.
In order to localize differences in individual deep white matter
tracts between groups, a Multivariate Analysis of Variance
(Manova) was applied to all three groups (healthy controls, HD
patients and Pre-HD subjects). Sex and age were included as
covariates in the model. After that, contrasts were run to
individuate the significant difference between groups.
All results were corrected using a False Discovery Rate (FDR)
correction, where order ranked p-values less than the resulting q-
value were considered significant. Practically, results with a p-
value less than 0.03 were considered significant.
Results
Subject demographics are reported in Table 1. Pre-HD subjects
and HD patients differed in age and CAG repetition length, but
not in gender. Additionally, as expected, HD patients had
significantly poorer performances with respect to all measures
assessed by the UHDRS, and also a significantly higher score of
Disease Burden.
Total Deep White Matter Findings
Results are shown in Figure 1.
Statistical details are outlined in Table 2.
FA: Pre-HD subjects did not have significantly reduced FA. HD
patients had reduced FA compared to Pre-HD subjects and
controls.
AD: Pre-HD subjects had increased AD compared to controls.
HD patients had increased AD compared to Pre-HD and control
subjects.
RD: Pre-HD subjects showed increased RD compared to
controls. HD patients also had increased RD compared to Pre-HD
subjects and controls.
R2*: R2* values were elevated in Pre-HD subjects both
compared to controls and HD patients. HD patients did not have
different values of R2* compared to controls.
We explored the individual covariates’ effect on white matter
parameters, we found that age has an impact on diffusivity
differences (AD and RD) between Controls and Pre-HD subjects,
that results in the loss of statistical significance. All other results
remain significant in the same direction. We did not find any effect
of gender on the white matter parameters.
Hemisphere Deep White Matter
Results are shown in Figure 2.
Hemisphere deep white matter is the combined total of the deep
white matter tracts for the left and, separately, for the right
hemisphere. Statistical details are outlined in Table 2.
FA: Pre-HD subjects had reduced FA in the right hemisphere
deep white matter and HD patients had reduced FA in both the
left and right hemisphere deep white matter compared to both
Pre-HD and control subjects.
AD: Pre-HD subjects had increased right hemisphere AD
compared to controls. HD patients had increased AD compared to
Pre-HD and control subjects in both hemispheres.
RD: Pre-HD subjects showed bilateral increases in RD
compared to controls and HD patients had elevated bilateral
RD compared to Pre-HD subjects and controls.
R2*: R2* values were elevated in both hemispheres within Pre-
HD subjects compared to both controls and HD patients. HD
patients did not have different values of R2* compared to controls.
Individual Deep White Matter tract Findings
Results are shown in Figure 2 and Figure 3.
Statistical details of tractography analysis of the individual deep
white matter tracts are in Table 3 and Table S2.
FA: Pre-HD subjects revealed, compared to controls, lower FA
in the right SLF, IFO and UF for Pre-HD subjects. In
comparisons to controls, HD patients had lower FA bilaterally
in the AF, SLF, Cing, IFO, ILF, and UF. Finally, FA analyses
between Pre-HD subjects and HD patients revealed reductions in
HD patients bilaterally in the AF, SLF, Cing, IFO as well as the
right ILF.
AD: Pre-HD subjects exhibited, compared to controls,
increased AD bilaterally in the SLF and ATR. AD analysis
between HD patients and controls revealed increased AD
bilaterally in the AF, SLF, IFO, and ATR as well as the left ILF
and right UF. Furthermore, when comparing Pre-HD subjects
with HD patients, HD patients had increased AD bilaterally in
AF, SLF, IFO, and ATR as well as the left ILF.
RD: Pre-HD subjects, compared to healthy controls, showed
significant increased RD in the SLF, and ATR bilaterally, as well
as the right IFO. HD patients also showed increased RD
compared to healthy controls bilaterally in the AF, SLF, Cing,
ILF, IFO, ATR, and UF. Finally, Pre-HD subjects had lower RD
compared to HD patients bilaterally in the AF, SLF, Cing, ILF,
IFO, ATR and right UF.
R2*: The analysis between Pre-HD subjects and controls
revealed increased R2* values in Pre-HD subjects in the left AF
and right Cing and IFO. There were no differences in R2* values
between HD patients and controls. However, when comparing
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Pre-HD subjects and HD patients, Pre-HD subjects had increased
R2* values bilaterally in the IFO as well as in the left AF, SLF and
right Cing, ILF and ATR.
Discussion
This study sought to identify variations in the deep white matter
(total and individual tracts) of Pre-HD subjects and HD patients
compared to each other and to healthy controls. A number of
major findings emerged from the results: (1) increases in AD and
RD in total deep white matter are present in Pre-HD subjects
before disease onset; (2) Pre-HD subjects show increased total deep
white matter iron content (R2* values) compared to both controls
and HD patients; (3) changes in individual white matter tracts in
Pre-HD are pervasive and become worse as the disease progresses.
Postmortem studies have repeatedly demonstrated the striking
myelin breakdown and white matter atrophy in HD [31].
Furthermore, a HD mouse model [32], found thinner myelin
sheaths and increased myelin periodicity (that is less compacted
the white matter). Also, an increasing number of white matter DTI
studies on human subjects have found extensive distributed
changes to white matter microstructure both in Pre-HD and
HD subjects [9–13,33–36]
Our current findings on total deep white matter are in line with
these previous works. We found an increase in AD and RD in Pre-
HD subjects compared to healthy controls and abnormalities
become significantly worse in HD. The precise biological meaning
of the DTI parameters is still unclear [17] and caution should be
used in interpreting the results. However, AD a measure of how
fast diffusion occurs in the preferred direction, has been shown to
be sensitive to the number of axons, as well as their coherence
[37]. Increased AD is related to white matter axonal atrophy likely
associated with Wallerian degeneration [38]. RD is a measure of
how fast diffusion occurs in the perpendicular direction. Increased
RD is thought to reflect reductions in myelination [39].
These white matter changes can be interpreted as a manifes-
tation of the pathology’s evolution. Indeed, our data suggests that
the deep white matter incurs early axonal atrophy (increased AD)
and myelin damage (increased RD) even before measurable
symptoms appear (Pre-HD stage), and this insult to deep white
Figure 1. Total Deep White Matter Tractography and Group Comparison. Bar graphs show differences between Total Deep White Matter
FA, AD, RD, and Iron. The error bars represent the Standard Error Mean (SEM). Legend. FA= Fractional Anisotropy; AD=Axial Diffusivity; RD=Radial
Diffusivity. (AD/RD Mean units: 1023 mm2/s, R2* (1023 mm1/s). * Significant difference between Pre-HD and Controls+ Significant difference between
Pre-HD and HD.
doi:10.1371/journal.pone.0109676.g001
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matter increases progressively as the disease progresses (stage I and
II). However, it is important to keep in mind the hypothesis that
abnormal brain development may contribute to the pathogenesis
of HD, as a precursor to the more global neurodegeneration
process [40]. Future longitudinal studies are needed to examine if
deep white matter changes are already in place in young Pre-HD
subjects.
In order to explore the underlying mechanism of deep white
matter abnormalities in HD, we examined the iron content. We
found a significant increase in iron content within Pre-HD subjects
compared to both healthy controls and HD patients. This suggests
that a repair mechanism is active in Pre-HD subjects, and it may
lead to an increase in oligodendrocytes before disease onset. The
data is in line with previous reports on iron levels in Pre-HD
subjects. In fact, extremely elevated numbers of oligodendrocytes
have been reported years before symptom appearance [41–43].
The ability to repair appears to keep the brain working with
minimal symptoms early in the disease and may be why white
matter damage has not been identified to be a central part of HD.
The repair mechanism may mask the downstream effects the
damage causes.
Furthermore, because HD patients have substantially impaired
total deep white matter compared to Pre-HD subjects, it may
indicate that the repair process is failing. There are two likely
reasons for this. One, the oligodendrocytes themselves may be
abnormal and thus they do not function correctly and/or the
accumulation of oligodendrocytes could be helpful at first, but may
be harmful once the levels become too high by causing neuronal
excitotoxicity and promoting free radical toxicity [2]. Either of
these possibilities fit with the idea that the HD brain is continually
trying to remyelinate in a losing attempt to compensate for the
disease-related myelin loss [2]. In HD, these remyelination
processes may successfully compensate during younger years,
which usually correspond to the beginning of the pathology or to
the years before onset (Pre-HD stage), but eventually begin failing
in older years as brain myelin volume continues to grow and the
maintenance of this expanding volume becomes increasingly
difficult. This is similar to what happens in healthy older
individuals [44] and likely explains the decrease in iron content
that we found between Pre-HD and HD subjects.
Interestingly, myelin may play a role in producing adenosine
triphosphate (ATP) [46], if this is the case, damage to the total
deep white matter could have a substantial impact on the brain’s
available energy, however, future studies will be needed to verify
this.
The R2* measurement has some limitations. Indeed it is
sensitive to increases in tissue iron, which increases the R2* value
[45] but it is not a specific measure of iron. In fact, many other
tissue changes, including myelination, calcifications, blood flow,
and increased tissue water, can influence the R2* measure.
Although R2* is not an exclusive measure of iron, combined
with diffusivity parameters it helps us reach a conclusion regarding
the data. This is because as our DTI findings in Pre-HD subjects
indicate tissue damage with more water and myelin damage (see
changes in diffusivity Figure 1 and 2), both factors should lower
the R2* values in our data. However, we still found higher R2*
values in Pre-HD group (Figure 2). This suggests that higher R2*
values reflect greater iron in our Pre-HD group.
Furthermore, shimming effects were controled for using the
protocol outlined in Peran et al. [27].
However, in the future, higher Tesla strengths, such as 7T or
above, and phase images (more related to the iron content) or
quantitative susceptibility mapping should be investigated to
confirm this data.
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In order to identify whether the changes in the deep white
matter were localized to individual tracts or presented in a pattern,
we examined each tract’s microstructure. When comparing
controls and Pre-HD subjects, we found the ILF tract was spared
in Pre-HD subjects (no difference in FA, AD, RD and iron level).
We also found that the AF and Cing did not show any
microstructure changes (no difference in FA, AD, RD) but they
present a higher level of iron unilaterally (left side for the AF, right
side for the Cing) which indicates that the repair mechanism is
working in these fibers, hiding the microstructural damage. We
further found the IFO and UF were damaged unilaterally
(decreased right FA, and increased RD for the IFO, decreased
right FA for the UF) and increased iron level in the right IFO
which indicates that the repair mechanism is at a breaking point,
with both high level of iron and microstructural damage
detectable. Finally, we found that the SLF and the ATR were
the most damaged tracts at the microstructural level (increased of
AD and RD bilaterally) and no difference in iron, which indicates
that the repair mechanism already failed in those fibers, and the
damage progressed to impair both sides of the tracts.
Thus, it seems that individual white matter tracts are impaired
in a specific manner in Pre-HD subjects, and it is possible to
describe a pattern in the tract damage, going from spared (ILF), to
more damaged (SLF and ATR), passing through those only
partially damaged (IFO and UF) to those damaged and under
repair (AF and Cing).
When we compare Pre-HD subjects with HD patients, the fibers
already damaged in the Pre-HD phase, proceed in a peculiar way.
The ILF, initially spared in Pre-HD, becomes impaired in HD
(increased AD on the left side; increased RD bilaterally; increased
iron on the right side); the AF and Cing, initially with a spared
microstructure in Pre-HD, show bilateral microstructural changes
in HD; the IFO, damaged unilaterally in Pre-HD, becomes
impaired bilaterally in HD; the UF remains stable and relatively
spared in both Pre-HD and HD; the SLF and the ATR, already
damaged in the Pre-HD phase, become increasingly impaired. We
found a high level of iron in Pre-HD compared to HD at the level
of the SLF and the ATR, which was not present when Pre-HD
subjects were compared with controls, which suggests a repair
mechanism was active but is no longer working in HD patients.
Thus it seems that in our sample group: the SLF and ATR are
fibers involved in the early phase of the pathology (Pre-HD) while
the IFO is relatively spared early but worsens quickly unlike the
UF which is more spared throughout the course of the pathology.
The difference in the individual white matter tracts damage (i.e.
unilateral or bilateral involvement, early or late involvement in the
course of the pathology) may be due to their different function
and/or structure. As for the function, it seems there is a link
between the fibers we have found damaged or spared (as the UF)
and some aspects of the disease. For example, the ATR is involved
in executive function and planning complex behaviours and
working memory and encoding of new stimuli [47]. The SLF, with
its three subcomponents SLFI SLFII and SFLII, is involved in
regulation of higher aspects of motor behavior, in spatial attention
and in gesture [48,49]. The IFO is involved in the awareness and
use of visual information for the purpose of guiding movements
and in the preparation and release of reaching-grasping arm
movement [50] as well as the execution of language processing
[49]. The UF, which is the spared one, is linked with the
regulation of auditory stimuli and recognition memory [50] and
likely plays a role in the language network [49]. However, despite
our growing understanding of the deep white matter tracts, there is
still much we do not yet know about their function thus, cautious
consideration is warranted before drawing conclusions between
the HD symptomology and specific tracts.
As for the structure, there is some evidence that HD might
preferentially damage large early myelinating fibers such as those
in the isthmus/splenium of the corpus callosum, which connect to
the occipital lobe [13,14,33]. Large fibers can be advantageous
because they encode more information but even a simple doubling
in firing rate appears to more than quadruple an axon’s energy use
[51]. Large early myelinating high caliber fibers might thus be
particularly susceptible. However, all the tracts had significantly
worse microstructure as the disease progressed, with changes in
Figure 2. Individual Deep White Matter Tractography and Group Comparison. Bar graphs show differences between Deep White Matter
Tracts FA, AD, RD, and Iron. The error bars represent the Standard Error Mean (SEM). Legend. FA= Fractional Anisotropy; AD=Axial Diffusivity;
RD= Radial Diffusivity. (AD/RD Mean units: 1023 mm2/s, R2* (1023 mm1/s) Tracts are from a representative single subject. Legend. Hemi DWM= total
Deep White Matter for each hemisphere, it is the result of the individual white matter tracts combined, AF =Arcuate Fasciculus, SLF = Superior
Longitudinal Fasciculus, Cing =Cingulate, ILF = Inferior Longitudinal Fasciculus, IFO= Inferior Frontal Occipital fasciculus, ATR =Anterior Thalamic
Radiation, UF =Uncinate Fasciculus.
doi:10.1371/journal.pone.0109676.g002
Figure 3. Deep White Matter Microstructure for Each Group.
Tracts shown use colour to represent the overall microstructure for each
tract within each group. White =Normal, Yellow=Abnormal, Red= -
Damaged. Tracts Legend. AF = Arcuate Fasciculus, SLF = Superior
Longitudinal Fasciculus, Cing=Cingulate, ILF = Inferior Longitudinal
Fasciculus, IFO = Inferior Frontal Occipital fasciculus, ATR =Anterior
Thalamic Radiation, UF=Uncinate Fasciculus.
doi:10.1371/journal.pone.0109676.g003
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Table 3. Individual Deep White Matter Tractography Group Comparisons.
Region Parameters MANOVA Control vs Pre-HD Control vs HD Pre-HD vs HD
F df P P P P
FA 11.72 2,95 0 0.128 0.001 0.007
Hemi DWM L AD 41.226 2,95 0 0.033 0.001 0.001
RD 42.081 2,95 0 0.002 0.001 0.001
R2* 3.956 2,85 0.023 0.027 0.392 0.009
FA 15.459 2,95 0 0.025 0.001 0.008
Hemi DWM R AD 32.857 2,95 0 0.013 0.001 0.001
RD 33.854 2,95 0 0.004 0.001 0.001
R2* 4.217 2,85 0.018 0.007 0.945 0.023
FA 9.489 2,95 0.000 0.284 0.001 0.008
AF L AD 7.662 2,95 0.001 0.358 0.001 0.014
RD 12.412 2,95 0.001 0.097 0.001 0.007
R2* 4.184 2,85 0.018 0.009 0.921 0.018
FA 9.259 2,95 0.001 0.204 0.001 0.013
AF R AD 5.869 2,95 0.004 0.832 0.001 0.011
RD 12.739 2,95 0.001 0.183 0.001 0.003
R2* 0.106 2,85 0.899 0.773 0.809 0.647
FA 10.908 2,95 0 0.132 0.001 0.010
SLF L AD 25.772 2,95 0 0.007 0.001 0.001
RD 26.074 2,95 0 0.003 0.001 0.001
R2* 5.118 2,85 0.008 0.035 0.133 0.002
FA 14.621 2,95 0 0.023 0.001 0.013
SLF R AD 18.941 2,95 0 0.020 0.001 0.002
RD 22.77 2,95 0 0.002 0.001 0.004
R2* 2.184 2,85 0.119 0.194 0.276 0.040
FA 11.218 2,95 0 0.453 0.001 0.001
Cing L AD 1.282 2,95 0.282 0.131 0.366 0.603
RD 18.397 2,95 0 0.052 0.001 0.001
R2* 2.331 2,85 0.103 0.092 0.499 0.042
FA 5.607 2,95 0.005 0.852 0.002 0.006
Cing R AD 0.573 2,95 0.566 0.343 0.850 0.339
RD 7.015 2,95 0.001 0.904 0.001 0.003
R2* 3.669 2,85 0.03 0.018 0.721 0.019
FA 8.587 2,95 0 0.089 0.001 0.050
ILF L AD 7.036 2,95 0.001 0.768 0.001 0.002
RD 12.574 2,95 0 0.218 0.001 0.002
R2* 1.804 2,85 0.171 0.193 0.395 0.064
FA 7.896 2,95 0.001 0.337 0.001 0.014
ILF R AD 2.333 2,95 0.102 0.764 0.035 0.129
RD 10.176 2,95 0 0.381 0.001 0.003
R2* 3.79 2,85 0.027 0.056 0.235 0.008
FA 8.716 2,95 0 0.146 0.001 0.027
IFO L AD 15.865 2,95 0 0.277 0.001 0
RD 23.041 2,95 0 0.064 0.001 0
R2* 3.781 2,85 0.027 0.050 0.262 0.008
FA 17.85 2,95 0 0.006 0.001 0.014
IFO R AD 19.794 2,95 0 0.595 0.001 0
RD 47.271 2,95 0 0.005 0.001 0
R2* 7.113 2,85 0.001 0.003 0.327 0.001
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FA, AD and RD involving the tracts bilaterally. In particular
though, across the DTI parameters (FA, AD, RD), the parameter
that was most sensitive to disease effects was RD, indeed each
individual tract (AF, SLF; Cing, ILF, IFO and UF) presented an
increase in RD for HD patients.
Again our data is in line with the accumulating number of DTI
studies of Pre-HD and HD subjects that have looked at white
matter. For example, a very recent paper showed extensive
alterations to white matter in HD that effects many different
anatomical regions [12] and others are rapidly uncovering similar
findings [9–11]. Because these abnormalities in white matter are
being reliably found despite different populations and different
methodological approaches, it strongly suggests that there may be
a common mechanism damaging white matter across the whole
brain in HD. This is important because damage to white matter is
extremely detrimental to the brain. There are extensive reasons for
this and they are covered in detail by Bartzokis [16]). In short, 1)
synapses depends on axonal transport for survival and this is
disrupted when white matter is damaged; 2) repair is extremely
energetically expensive; 3) repaired myelin is not as good (thinner
sheaths, increased number of internodes) as the original undam-
aged one.
Conclusions
White matter is critical to the human brain’s complexity [16]
and we have shown that it is damaged in Pre-HD years before
symptoms occur in a specific pattern. Furthermore, Pre-HD
subjects attempt to repair this damage but fail as the disease
progresses. Finally, the data presented supports the conclusion that
changes to deep white matter are a central component of HD.
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